embryonal tumor of neuroepithelial tissue
ORPHA: 2518522 Treatments Available
Overview
human disease
Available Treatments (2)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| temozolomide Orphan | oral capsule, 5 mg, 20 mg, 100 mg, 140 mg, 180 mg, 250 mg | FDA Approved, EMA Approved | 10 | 7d |
| bevacizumab Cold Chain | IV infusion, 25 mg/mL solution; intravitreal injection (off-label) | FDA Approved, EMA Approved | 12 | 14d |
Classification & Codes
Orphanet Code
ORPHA:251852embryonal tumor of neuroepithelial tissue
| Orphanet | ORPHA:251852 |
| Treatments | 2 drug(s) |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO